6-(4-cyclopropylpiperazin-1-yl)-2′-methyl-[3, 4′]-bipyridine and its uses as a medicament
View Patent ↗6-(4-Cyclopropylpiperazin-1-yl)-2′-methyl-[3,4′]bipyridinyl and salts and hydrates thereof interact with the histamine H3 receptor are defined.
1. A compound of Formula (I)
or a pharmaceutically acceptable salt thereof.
2. The compound of claim 1 , where the compound is in the form of a hydrochloride salt.
3. The compound of claim 2 , where the compound is in the form of a trihydrochloride salt.
4. The compound of claim 1 , where the compound is in the form of a trifluoroacetate salt.
5. The compound of claim 4 , where the compound is in the form of a mono-trifluoroacetate salt.
6. A pharmaceutical composition comprising: a compound of Formula (I)
or a pharmaceutically acceptable salt thereof; and a pharmaceutically acceptable carrier or diluent.
7. The pharmaceutical composition of claim 6 , where the compound is in the form of a hydrochloride salt.
8. The pharmaceutical composition of claim 7 , where the compound is in the form of a trihydrochloride salt.
9. The pharmaceutical composition of claim 6 , where the compound is in the form of a trifluoroacetate salt.
10. The pharmaceutical composition of claim 9 , where the compound is in the form of a mono-trifluoroacetate salt.